reporting systems, and the fact that there are always additional case reports in the reporting pipeline. This paper is presented in two parts, the first dealing with a brief history of AIDS and the second with an update of the problem in the Veterans Administration.
BRIEF HISTORY OF AIDS General Overview
The disease, AIDS, now known to be caused by a virus (human immunodeficiency virus, HIV), has probably existed in this country for at least seven years. The term "AIDS" is appropriately used to refer to a spectrum of illnesses caused by the HIV. The protean clinical manifestations of AIDS bring to mind the Oslerian aphorism: "To know syphilis is to know medicine." That statement is gaining further meaning in relation to AIDS.
The disease may have originated in central Africa, migrated to western Europe, and the Caribbean, and thence into the United States. Some see America as having exported the disease to other parts of the world in recent years. In any case, the disease is now worldwide in its distribution, having been reported in over 100 countries [1] . The disease's historical evolution through 1984 is portrayed in Table 1 .
Far more impressive is the 1986 data and projected data beyond 1986 (Report of the Coolfont Planning Conference, June [4] [5] [6] 1986) [2] . At the end of 1991, for example, the projected cumulative number of cases is 270,000, with the cumulative deaths at the end of that year estimated to be 179,000. These numbers reflect only those cases that meet the current CDC definition for AIDS and do not include the increasing array of clinical manifestations being reported in the literature that may not meet the moderately restrictive CDC surveillance definition. These clinical manifestations are grouped under the diagnosis of AIDS-related complex (ARC).
Those individuals presumed to be infected number from one to two million. An alarming note is the frequency with which those who possess antibodies to AIDS are 
Epidemiology
The epidemiology has been well worked out by officials at the CDC and others [1, 2, 3, 4] . At present (Spring 1987) over 36,000 cases have been reported to CDC (Fig.  1) , with a cumulative mortality rate of 56 percent. The case fatality rate for frank AIDS approximates 100 percent.' Risk-group patterns have received much attention. Table 2 lists the population groups at greatest risk. Clearly, members of the first two risk groups, namely homosexual/bisexual males and intravenous (IV) drug abusers, are at greatest risk and have rather consistently represented about 89-90 percent of the total. The relationship among the various groups has remained relatively constant since the inception of the epidemic. That two of the nation's major health problems (i.e., drug abuse and AIDS) are interwoven is now evident.
At present 7 percent of the total cases are in heterosexual men and woman. The percentage of the total cases among heterosexual men and women is predicted to increase modestly to 9 percent by 1991. We do know that AIDS can be transmitted bi-directionally, although male-to-female spread appears to be far more likely than the converse. cally prior to the availability of the AIDS screening tests, some of the really tragic proportions of the AIDS epidemic begin to unfold. Blood transfusion recipients represent about 2 percent of the total number of cases. This group has the potential to diminish to zero in terms of new cases because of mandatory testing of all donor blood and plasma. "Project look-back" (a program implemented by the nation's blood collection agencies) has as its goal identification and communication of all contaminated donor blood identifier numbers to medical centers to which that blood was distributed for possible transfusion. Patients who received contaminated transfusions are to be contacted and counselled. Because of the timing of the availability of the AIDS-antibody test (Spring 1985) , additional cases may be reported, since the latency period for developing AIDS may be as long as five years or more. Figure 2 demonstrates the overlap between the two leading risk groups. Examining the data in another way, one concludes that the IV drug user group represents a higher percentage than that shown in Tables 3 and 4 , since IV drug users are included among the homosexual/bisexual group where both risks are present in the same individual. Approximately 25 percent of all AIDS cases appear to involve intravenous drug use. In the New York City area, cases belonging to the IV drug abuser group represent 34 percent of the total there.
As is now well known, it was the occurrence of Pneumocystis carinii pneumonia (PCP) and other unusual infections in previously healthy male homosexuals that United States, Aug. presaged the AIDS epidemic [6] . The myriad of opportunistic infections that have been associated with AIDS are listed in Table 5 [7]; the list is not all-inclusive. Classification ofAIDS Several different classification schemata for AIDS have been developed. The CDC classification system [4] is shown in Table 6 . It should prove useful in the design and evaluation of clinical investigation trials.
Of special importance are the neuropsychiatric manifestations of infection with HIV [5] . Approximately 30 percent of patients with AIDS have nervous system involvement. This involvement may take many forms: a progressive dementing encephalitis, a diffuse encephalopathy, focal brain abnormalities, or cranial and peripheral neuropathies. The central nervous system (CNS) of patients with AIDS is also vulnerable to a variety of opportunistic infections, including T. gondii and cryptococcosis. An increased incidence of CNS neoplasms, especially lymphomas, is also observed.
Thoroughgoing psychiatric and psychosocial management of patients with AIDS is particularly important but may be alarmingly absent from the overall treatment plan.
AIDS PROGRAM IN THE VETERANS ADMINISTRATION Initiation of VA AIDS Program
The Veterans Administration admitted, in 1981, its first patient who subsequently was found to have AIDS. In 1983, a formal reporting system was initiated for patients provided risk factor information. Of these, 44 percent were homosexual/bisexual males and 26 percent were IV drug abusers. Seven percent gave a history of both. (Refer to Table 4.) Since the patient treatment file (PTF: an automated data-processing system for storing clinical data on VA patients) has not distinguished AIDS from ARC until the current fiscal year, no reliable data exist on mean length of hospital inpatient stay. An unpublished study of 90 VA cases (the last ten patients discharged from nine VAMCs in fiscal year 1986) showed, however the average length of stay to be 21.9 days, with each patient averaging 2.5 admissions in fiscal year 1986. Length of stay data varies with location. Patients in the four greater New York area hospitals had an average length of stay of 27.8 days with 2.9 admissions, while the three California hospitals showed 12.6 days and 3.0 admissions. Seventy percent of the New York cases were IV drug abusers, while only 20 percent of those in California were.
The VA, early on, established health care policy guidelines in relation to the management of AIDS patients and patients with the spectrum of illnesses caused by the HIV (human immunodeficiency virus) [8] . The overriding policy for the Department of Medicine and Surgery (DM&S) is to provide quality medical care to all eligible veterans in a timely and compassionate manner. This policy objective is no different for patients with AIDS.
The VA established firmly that VA employees were expected to provide care to veterans with AIDS, and there have been relatively few incidents that reached Central Office level. The emphasis has been on continuing education of staff and patients and clear guidance that these patients are veterans who have earned the care through service to our country.
The VA provides the entire spectrum of health care, including acute and extended hospital care, nursing home care, hospital-based home care, and domiciliary and residential care placement. AIDS patients are receiving care in VA nursing homes, although placement in community nursing homes has been difficult. These are also patients with AIDS living in VA domiciliaries which provide a relatively independent living environment with medical supervision on the grounds of VA medical centers.
VA Update
Recently, a decision was made to fund an AIDS unit at the Manhattan VA Medical Center. A request for proposals (RFP) will be sent to seven additional medical centers experiencing relatively large AIDS-related workloads. It is expected that two or three additional units wll be created.
The issues surrounding AIDS are legion. The author, in the course of preparing a videotape for the VA health care system, identified over twenty different issues, not the least of which were human T-cell lymphotropic virus type III (HTLV-III) or HIV screening, risks to health care professionals, psychosocial aspects in the management of patients with AIDS, confidentiality of records, homophobia, and so on.
In the early years (1982 and 1983), it seemed that relatively few people were taking this disease seriously. Obviously the direct care givers were! We find the situation remarkably different today. One statistic which tends to gain immediate attention is that taken from the report of the Coolfont Planning Conference held in June 1986, in Berkeley Springs, West Virginia (Public Health Service Plan for the Prevention and Control of AIDS and the AIDS Virus), referred to earlier in this article. As stated, the projected number of cumulative cases to be diagnosed (given present trends) at the end of 1991 -the tenth aniversary of this disease in the United States-is 270,000. The VA has regularly seen, based on the aforementioned VA reporting system, approximately 6 percent of the total number of cases reported by the Centers for Disease Control. Again, using the same assumptions and current trends, we would project that over 16,000 cases, cumulatively, would be treated in the VA health care system by the end of 1991. Of course, these figures will be revised downward should major therapeutic and/or preventive breakthroughs occur.
Costs of Caringfor AIDS Patients
AIDS patients do not fit well into the diagnosis-related groups (DRG)-driven reimbursement methodology utilized by the VA. There have been numerous attempts both in the VA and out to arrive at cost projections per case. In order to be responsive to individual facility needs, VA Central Office has attempted to find a more rational way of funding facilities for AIDS cases. A facility's resources are based on the workload performed two fiscal years previously. Because AIDS is a comparatively new disease that is increasing at a rapid rate and is unevenly distributed around the country, it represents a special challenge for the relatively few VA centers that care for the majority of the agency's AIDS workload. In fiscal year 1985, we estimated that it cost $38,000 per year to treat an AIDS patient. A more recent study determined that $24,000 a year is a more appropriate figure. A questionnaire, which was sent to 11 facilities that had a high number of reported AIDS cases, was devised. The questionnaire asked for certain information concerning the facility's last ten AIDS patients in fiscal year 1986. Using this data, we estimated that the Resource Allocation Methodology (the diagnosis-related groups [DRG]-driven system) provided funding of approximately $8,000 per AIDS case to VA medical centers, obviously resulting in a shortfall.
Based on reduced lengths of stay, less use of intensive care unit days, and improved facilities to manage these patients, it is believed that the cost of an AIDS patient has decreased about 20 percent since fiscal year 1985. As a result, the VA is using $20,000 as an estimate of cost per patient per year for fiscal year 1987. Based on this estimate, supplemental funding was provided for those facilities that cared for more than 15 cases in fiscal year 1987.
Although treatment costs appear to be coming down, the treatment outlook is unchanged (except for the emergence of zidovudine, formerly called AZT, for selected cases). Increased use of this drug will tend to offset reduced costs; the drug itself costs from $7-10,000 per year per patient. Also, since the drug is toxic and requires close monitoring, including various laboratory studies, additional costs will be incurred. Educational Activities In fiscal year 1986, the Regional Medical Education Centers (RMECs) conducted 12 continuing education activities, training 1,240 VA participants on the subject of AIDS. In addition, in fiscal year 1986 the Cooperative Health Manpower Education Programs (CHEPs) trained 53 VA participants in four continuing education activities. In fiscal year 1987 to date, the RMECs have trained 440 VA participants in three continuing education activities.
Examples of these activities include: Care of the AIDS patient AIDS: Nursing concern and management AIDS overview and VA update AIDS: Psychosocial aspects
Results of a RMEC survey on AIDS training conducted at VA medical centers in fiscal year 1985 revealed that the majority of the training conducted was general information/orientation/awareness in content and involved staff from all services. Over 30,000 staff were trained at 129 VAMCs in fiscal year 1985.
The ten VA medical centers currently with the highest number of AIDS cases reported patient and family education activities involving a wide variety of topics. This information is available to inpatients, outpatients, and veterans in the community through VA Health Fairs as well as VA staff participation in community activities, including community nursing homes, volunteers, families and significant others, recovering drug abuse patients, "worried well" (exposed to virus and/or HIVpositive), and zidovudine (formerly AZT) protocol participants.
The Office of Academic Affairs in Central Office is establishing a comprehensive VA-wide AIDS patient and family education program. This assessment will include program components, target audiences, and print and non-print materials supporting educational activities and the name of the contact person of each VAMC, and will provide the information necessary to assist those VAMCs that need help in developing effective patient health education programs related to the following information:
HIV 1. b., above). CONCLUSION A brief overview of the historical evolution of AIDS, the epidemiology, and data on risk-group patterns has been presented. Certain clinical aspects are emphasized.
As with the nation at large, AIDS is having a significant effect on VA Medical Centers located in the coastal regions of the United States. The VA's overall experience, including morbidity and mortality data and definition of the groups at greatest risk, generally reflects that seen in the non-federal health care sector.
AIDS and AIDS-rela,ted diseases are grave illnesses, requiring all manner of commitment to high-quality clinical care, patient sensitivity, interagency collaboration, and innovative educational, research, and administrative activities.
The VA, as the nation's largest centrally directed public health care system, will continue to be responsive to these requirements.
